Jun 16, 2005|
FMCG: Small is beautiful!
Yesterday we wrote about how large FMCG companies performed in FY05 in comparison to FY04 and the picture was quite bleak. Today, we compare 5 other FMCG companies, albeit this time from the mid-cap space.The five companies included here are Dabur, Godrej Consumer Products, Colgate, Marico and Pidilite.
|Operating Profit (EBDIT)
|Operating Profit Margin (%)
|Profit before Tax
|Profit after Tax
|Net profit margin (%)
|Effective tax rate (%)
What does the report card say?
The consolidated topline grew by around 13% YoY in FY05 (below 6% YoY growth in the case of large-caps) indicating that smaller FMCG companies have benefited more from the increase in consumer spending, largely at the expense of the bigger players like HLL and Nestle. Also, the rise in expenditure was at a slower pace than the sales growth, which could be attributed to improved supply chain efficiencies, which the smaller companies have been working on for sometime now. This resulted in operating margins expand by 100 basis points (down 130 basis points for large FMCG companies). Had commodity (primarily oil) prices not risen drastically in FY05, the operational performance would have had been stronger. Depreciation increased by 7.5% YoY, mainly because of Dabur's acquisition of Balsara, which resulted in a 19% YoY rise for the company. Interest costs have reduced by around 8% as companies like Godrej Consumer and Dabur are working on negative working capital, indicating their cash flow management skills.
All these factors, clubbed together, resulted in a 27% YoY PAT growth for mid-cap FMCG companies compared to a 1% fall in profits for the larger ones. Of the 5 companies, Dabur and Godrej Consumers reported 46% and 38% YoY bottomline growth respectively. The only company to show a net profit increase of less than 10% was Colgate (5%), which was hit by rising oil prices owing to its inability to pass on the increased costs to consumers. The 15% price cuts, the company resorted to during the year, further dampened the performance. Nonetheless, it managed to keep its head above the water.
What to expect?
Mid-caps are currently the darlings of the market with every investor wanting to own them and in the process giving them valuations at par with the larger companies. We believe that selective mid-cap FMCG companies are a good investment option, though their commanding valuations, as compared to the well-established larger companies, make them somewhat risky. Nonetheless, in our view, the smaller FMCG companies have the potential to explore the untapped markets and are already gaining acceptance.
Also, since these companies follow a different strategy by offering higher margins to wholesalers and retailers, it results in their products being pushed more than others. Further, smaller companies have started exploring rural markets, not through their own network as it is an expensive affair, but through other larger companies networks. For example, Godrej Consumer has tied up with ITC to sell its soaps through the latter's E-Choupal network. However, the only drawback in this strategy is that of marginally lower margins.
The FMCG sector, after having underperformed for some time, is on the path to recovery, with acceleration in rural growth, increasing consumer spending along with the shift in product preference towards those being offered by the newer entrants. Also, with greater possibility of oil prices softening in the medium-term, pressure on operating margins of FMCG companies would stand reduced. Dabur and Pidilite remain our top picks in the sector currently and we have already given a BUY recommendation on both these stocks.
More Views on News
Aug 9, 2017
While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Dec 9, 2016
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
Nov 30, 2016
Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
Nov 30, 2016
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
Nov 28, 2016
Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.
More Views on News
Aug 17, 2017
A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.
Aug 10, 2017
Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.
Aug 16, 2017
The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?
Aug 10, 2017
Bitcoin hits an all-time high, is there more upside left?
Aug 16, 2017
Ensure your financial Independence, and pledge to start the journey towards financial freedom today!
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407